also expected to remain below expectation for the rest of FY 2019 due to ongoing weakness in IPA margin. The strength in the core businesses (Integrated PET, Fibers and Packaging) is likely to remain for
with chronic kidney disease. Present, patient who replacement therapy with dialysis with dialysis machines was increased steadily to fully capacity. Currently, there is still a plan for increasing the
a hemodialysis center to patients with chronic kidney disease. Present, patient who replacement therapy with dialysis with dialysis machines was increased steadily to fully capacity. And the second
significant events are as follows. 5.1 KT Medical Services Co., Ltd. operates a Hemodialysis center to patients with chronic kidney disease. Present patient who replacement therapy with Hemodialysis with
Driving entire presale and transfer. Moreover, company also take care of consumers and employees health with Zero-COVID patient. The company will maintain the standards and continuously improve to be able
health with Zero-COVID patient. The Group will maintain the standards and continuously improve to achieve the goal through this challenging PAGE 3 year. In addition, The Group also has a new joint venture
. Present patient who replacement therapy with Hemodialysis with Hemodialysis machines was increased steadily. For the second half year 2020 we have plans to start operation new 3 Hemodialysis centers with
kidney disease. Present patient who replacement therapy with Hemodialysis with Hemodialysis machines was Management’s discussion and analysis for Quarter 1’ 2020 7 / 7 increased steadily. For the year 2020
underperforming, investors need to remain patient,” CNBC, March 28, 2022. 4 สามารถดูข้อมูลเพิ่มเติมได้ที่ https://www.unpri.org/annual-report-2022/signatories 5 สามารถดูข้อมูลเพิ่มเติมได้ที่ https://www.sec.or.th
/06/21 https://www.invesco.com/us- rest/contentdetail?contentId=12d2fd05f0e21410VgnVCM100000c2f1bf0aRCRD&dnsName=us สัดสวนของประเภททรัพยสินที่ลงทุน https://www.ishares.com/us/literature/fact-sheet